MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Secured Loans History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Secured Loans | ₹5,078 Cr | ₹25 Cr | ₹23 Cr | ₹49 Cr | ₹57 Cr |
What is the latest Secured Loans ratio of MANKIND PHARMA ?
| Year | Secured Loans |
|---|---|
| Mar2025 | ₹5,078 Cr |
| Mar2024 | ₹25 Cr |
| Mar2023 | ₹23 Cr |
| Mar2022 | ₹49 Cr |
| Mar2021 | ₹57 Cr |
How is Secured Loans of MANKIND PHARMA Trending?
| Years | Secured Loans | % Change | |
|---|---|---|---|
| Mar2025 | ₹5,078 Cr | 20,317.49 | |
| Mar2024 | ₹25 Cr | 7.44 | |
| Mar2023 | ₹23 Cr | -52.71 | |
| Mar2022 | ₹49 Cr | -14.76 | |
| Mar2021 | ₹57 Cr | - | |
Compare Secured Loans of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹102,419.8 Cr | -0.6% | 11% | -1.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,725.0 Cr | -3.2% | 10.5% | 9.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,775.0 Cr | 0.8% | 9.5% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,764.0 Cr | 2% | 9.9% | 35.4% | Stock Analytics | |
| CIPLA | ₹113,007.0 Cr | -1.9% | 13.3% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,098.0 Cr | -1.8% | 7.4% | 8.2% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -0.6% |
11% |
-1.8% |
| SENSEX | 0.2% |
-4.9% |
-8.4% |
You may also like the below Video Courses